Table 3.
Characteristics of myasthenic crisis (2016–2018).
| Characteristics | 2016 (n = 442) | 2017 (n = 418) | 2018 (n = 608) |
|---|---|---|---|
| Age, mean (SD), y | 51.9 ± 18.4 | 53.0 ± 17.3 | 50.2 ± 19.6 |
| Sex (female), n (%) | 256 (57.9) | 243 (58.1) | 346 (56.9) |
| Length of hospital stay, median (IQR) | 15.0 (8.0 to 23.0) | 15.0 (8.0 to 25.0) | 14.0 (7.0 to 25.0) |
| Hospitalization cost, median (IQR), US$ | 3,521 (1,075 to 9,311) | 3,473 (1,044 to 9,076) | 3,408 (1,039 to 8,762) |
| Mortality characteristics | n = 31 | n = 31 | n = 33 |
| Age, mean (SD), y | 65.8 ± 13.1 | 61.1 ± 16.8 | 58.9 ± 22.5 |
| Sex (female), n (%) | 15 (48.4) | 13 (41.9) | 17 (51.5) |
| Department, n (%) | |||
| Neurology | 12 (38.7) | 12 (38.7) | 12 (36.4) |
| Critical Care Medicine | 10 (32.3) | 11 (35.5) | 9 (27.3) |
| Respiratory | 2 (6.5) | 1 (3.2) | 1 (3.0) |
| Oncology | 2 (6.5) | 1 (3.2) | 0 |
| Emergency | 0 | 1 (3.2) | 3 (9.1) |
| Thoracic Surgery | 1 (3.2) | 2 (6.5) | 1 (3.0) |
| Other | 4 (12.9) | 3 (9.7) | 7 (21.2) |
| Causes*, n (%) | |||
| Respiratory failure | 17 (54.8) | 24 (77.4) | 19 (61.3) |
| Electrolyte disorders | 19 (61.3) | 13 (41.9) | 24 (77.4) |
| Lung infection | 5 (16.1) | 5 (16.1) | 6 (19.4) |
| Diabetic ketoacidosis | 7 (22.6) | 3 (9.7) | 6 (19.4) |
| Hypoproteinemia | 9 (29.0) | 6 (19.4) | 10 (32.3) |
⁎
Top 5 death related diseases.